ION BEAM APPLICATIONS (IBAB.BR) Fundamental Analysis & Valuation

EBR:IBAB • BE0003766806

Current stock price

13.62 EUR
-0.16 (-1.16%)
Last:

This IBAB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. IBAB.BR Profitability Analysis

1.1 Basic Checks

  • IBAB had positive earnings in the past year.
  • In the past year IBAB had a positive cash flow from operations.
  • Of the past 5 years IBAB 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
IBAB.BR Yearly Net Income VS EBIT VS OCF VS FCFIBAB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • IBAB has a Return On Assets (2.71%) which is comparable to the rest of the industry.
  • With an excellent Return On Equity value of 14.29%, IBAB belongs to the best of the industry, outperforming 84.48% of the companies in the same industry.
  • The Return On Invested Capital of IBAB (16.28%) is better than 93.10% of its industry peers.
Industry RankSector Rank
ROA 2.71%
ROE 14.29%
ROIC 16.28%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBAB.BR Yearly ROA, ROE, ROICIBAB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • IBAB's Profit Margin of 2.85% is on the low side compared to the rest of the industry. IBAB is outperformed by 60.34% of its industry peers.
  • In the last couple of years the Profit Margin of IBAB has declined.
  • Looking at the Operating Margin, with a value of 6.48%, IBAB is in line with its industry, outperforming 41.38% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IBAB has declined.
  • The Gross Margin of IBAB (31.21%) is worse than 81.03% of its industry peers.
  • In the last couple of years the Gross Margin of IBAB has declined.
Industry RankSector Rank
OM 6.48%
PM (TTM) 2.85%
GM 31.21%
OM growth 3Y17.29%
OM growth 5Y-18.98%
PM growth 3Y6.89%
PM growth 5Y-27.51%
GM growth 3Y-2.84%
GM growth 5Y-5.9%
IBAB.BR Yearly Profit, Operating, Gross MarginsIBAB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. IBAB.BR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBAB is creating value.
  • IBAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IBAB.BR Yearly Shares OutstandingIBAB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
IBAB.BR Yearly Total Debt VS Total AssetsIBAB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • IBAB has an Altman-Z score of 1.71. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
  • IBAB has a worse Altman-Z score (1.71) than 65.52% of its industry peers.
  • IBAB has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of IBAB (0.23) is better than 65.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 1.71
ROIC/WACC2.04
WACC7.98%
IBAB.BR Yearly LT Debt VS Equity VS FCFIBAB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.94 indicates that IBAB may have some problems paying its short term obligations.
  • IBAB has a Current ratio of 0.94. This is amonst the worse of the industry: IBAB underperforms 82.76% of its industry peers.
  • IBAB has a Quick Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of IBAB (0.62) is worse than 81.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.62
IBAB.BR Yearly Current Assets VS Current LiabilitesIBAB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IBAB.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 41.86% over the past year.
  • The earnings per share for IBAB have been decreasing by -16.73% on average. This is quite bad
  • The Revenue has grown by 21.86% in the past year. This is a very strong growth!
  • IBAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.73% yearly.
EPS 1Y (TTM)41.86%
EPS 3Y27.82%
EPS 5Y-16.73%
EPS Q2Q%-21.38%
Revenue 1Y (TTM)21.86%
Revenue growth 3Y19.74%
Revenue growth 5Y14.73%
Sales Q2Q%8.09%

3.2 Future

  • IBAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.60% yearly.
  • IBAB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.86% yearly.
EPS Next Y78.85%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y3.53%
Revenue Next 3Y3.47%
Revenue Next 5Y-0.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IBAB.BR Yearly Revenue VS EstimatesIBAB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
IBAB.BR Yearly EPS VS EstimatesIBAB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. IBAB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 31.67, which means the current valuation is very expensive for IBAB.
  • IBAB's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of IBAB to the average of the S&P500 Index (27.35), we can say IBAB is valued inline with the index average.
  • IBAB is valuated correctly with a Price/Forward Earnings ratio of 13.16.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IBAB indicates a rather cheap valuation: IBAB is cheaper than 81.03% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of IBAB to the average of the S&P500 Index (22.23), we can say IBAB is valued slightly cheaper.
Industry RankSector Rank
PE 31.67
Fwd PE 13.16
IBAB.BR Price Earnings VS Forward Price EarningsIBAB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBAB indicates a rather cheap valuation: IBAB is cheaper than 81.03% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.29
IBAB.BR Per share dataIBAB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as IBAB's earnings are expected to grow with 35.60% in the coming years.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y38.16%
EPS Next 3Y35.6%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. IBAB.BR Dividend Analysis

5.1 Amount

  • IBAB has a Yearly Dividend Yield of 1.24%.
  • IBAB's Dividend Yield is comparable with the industry average which is at 1.30.
  • Compared to the average S&P500 Dividend Yield of 1.82, IBAB is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.24%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
IBAB.BR Yearly Dividends per shareIBAB.BR Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 8.05% of the earnings are spent on dividend by IBAB. This is a low number and sustainable payout ratio.
DP8.05%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
IBAB.BR Yearly Income VS Free CF VS DividendIBAB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M
IBAB.BR Dividend Payout.IBAB.BR Dividend Payout, showing the Payout Ratio.IBAB.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IBAB.BR Fundamentals: All Metrics, Ratios and Statistics

ION BEAM APPLICATIONS

EBR:IBAB (4/27/2026, 7:00:00 PM)

13.62

-0.16 (-1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-27
Earnings (Next)05-09
Inst Owners27.34%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner ChangeN/A
Market Cap412.41M
Revenue(TTM)620.22M
Net Income(TTM)17.00M
Analysts80
Price Target16.07 (17.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.24%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.28%
PT rev (3m)3.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.22%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 31.67
Fwd PE 13.16
P/S 0.69
P/FCF N/A
P/OCF 148.14
P/B 3.47
P/tB 4.37
EV/EBITDA 9.29
EPS(TTM)0.43
EY3.16%
EPS(NY)1.04
Fwd EY7.6%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.68%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.4
PEG (5Y)N/A
Graham Number6.16565 (-54.73%)
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 14.29%
ROCE 25.19%
ROIC 16.28%
ROICexc 17.24%
ROICexgc 20.74%
OM 6.48%
PM (TTM) 2.85%
GM 31.21%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y17.29%
OM growth 5Y-18.98%
PM growth 3Y6.89%
PM growth 5Y-27.51%
GM growth 3Y-2.84%
GM growth 5Y-5.9%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 0.54
Cap/Depr 65.94%
Cap/Sales 1.38%
Interest Coverage 250
Cash Conversion 5.44%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.62
Altman-Z 1.71
F-Score6
WACC7.98%
ROIC/WACC2.04
Cap/Depr(3y)87.67%
Cap/Depr(5y)76.45%
Cap/Sales(3y)2.06%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.86%
EPS 3Y27.82%
EPS 5Y-16.73%
EPS Q2Q%-21.38%
EPS Next Y78.85%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue 1Y (TTM)21.86%
Revenue growth 3Y19.74%
Revenue growth 5Y14.73%
Sales Q2Q%8.09%
Revenue Next Year3.13%
Revenue Next 2Y3.53%
Revenue Next 3Y3.47%
Revenue Next 5Y-0.86%
EBIT growth 1Y38.72%
EBIT growth 3Y40.44%
EBIT growth 5Y-7.05%
EBIT Next Year88.61%
EBIT Next 3Y37.43%
EBIT Next 5YN/A
FCF growth 1Y85.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.43%
OCF growth 3YN/A
OCF growth 5YN/A

ION BEAM APPLICATIONS / IBAB.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?

ChartMill assigns a fundamental rating of 3 / 10 to IBAB.BR.


What is the valuation status of ION BEAM APPLICATIONS (IBAB.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for ION BEAM APPLICATIONS?

ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 3 / 10.


What is the earnings growth outlook for ION BEAM APPLICATIONS?

The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 78.85% in the next year.


How sustainable is the dividend of ION BEAM APPLICATIONS (IBAB.BR) stock?

The dividend rating of ION BEAM APPLICATIONS (IBAB.BR) is 3 / 10 and the dividend payout ratio is 8.05%.